VEGFA and neoplasm: This occurs despite the fact that ARPCA does not affect the pro-angiogenic action of VEGF-A and may be related to its ability to affect both tumor epithelial and stromal compartments by suppressing the autocrine/paracrine action of FGF8b that is essential for the initial angiogenic and proliferative switch of tumor cells.